Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Rheumatoid Arthritis
How would you manage a patient with erosive seronegative rheumatoid arthritis with IgG and IgM deficiency?
Related Questions
Can Dupixent (dupliumab) be safely used in patients who are taking other biologics for rheumatic disease?
Would you switch to a TNF-I if patient developed squamous cell skin cancer on Orencia after failure of MTX for seropositive RA?
How do you approach treatment selection in patients with rheumatoid arthritis and severe COPD?
How do you approach treatment of a patient with active RA and a history of Lynch Syndrome?
Do you consider new onset autoimmune disease (e.g. seronegative rheumatoid arthritis) a few months after completing immunotherapy for cancer to be an immune-related adverse effect to the immunotherapy?
How would you approach rheumatoid arthritis treatment for widespread large rheumatoid nodules but no active synovitis or subjective joint pain?
How do you approach treating a patient with RA and cirrhosis who did not respond to csDMARDs?
What is your approach to assessing inflammatory arthritis flares in joints that have been replaced (such as knees)?
How do you approach the timing of DMARD initiation in patients with active RA who are on treatment for latent TB?
What is your approach to work up for patients referred for early onset osteoarthritis?
